Biohit Oyj - Company Announcement

CORRECTION: CLARIFICATION RELATED TO THE NOTICE OF ANNUAL GENERAL MEETING

Biohit Oyj April 5, 2013 at 4:30 P.M. local time (EET)



Resolution on the use of the result shown on the Balance Sheet and on dividend
payment 

The Board of Directors proposes that the profit for the financial period ended
on 31st of December 2012 be recorded in the profit and loss account. 
The Board of Directors proposes that on the basis of the financial statements
to be adopted for the financial period ended on 31st of December 2012, a
dividend of EUR 0,4964 (previously proposed EUR 0,49) per each A share and EUR
0,4998 for each B share be paid.  Dividend will be paid to shareholders
recorded in the company's shareholder register on the matching day, 11th of
April 2013. The Board of Directors proposes that the dividend will be paid out
on 18th  of April 2013. 



Additional information:

CEO Semi Korpela, Biohit Oyj
Tel. +358 9 773 861
semi.korpela@biohit.fi
www.biohit.fi



Biohit in brief

Biohit Oyj is a Finnish biotechnology company operating globally that was
established in 1988.Biohit's mission is "Innovating for Health".The purpose of
the company is to take social responsibility and produce innovation, new
technologies and analysis systems for use in medicine, research institutions
and industry, helping to promote research and diagnostics and to improve the
quality of life of people by means of preventing disease, human suffering and
financial loss.We are committed to social responsibility and it is our duty to
spread knowledge about the Group 1 human carcinogen, acetaldehyde, and innovate
and develop the marketing and availability of our products and services.Biohit
is headquartered in Helsinki and its subsidiaries are located in China and the
United Kingdom.Since 1999, Biohit's Series B shares (BIOBV) have been listed in
the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector.